Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ikko Muto

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Journal of Cutaneous Pathology|May 13, 2018
Adenodermatofibroma possessing dilated glandular structures with eccrine features: A case studyIkko Muto, Fumi Kuwahara, Takako Shintani, et al.
The Kurume Medical Journal|October 4, 2023
Efficacy of Nivolumab and Ipilimumab Combined Therapy as a First-Line Therapy for Patients with Advanced Melanoma and the Urgent Need for an Effective Second-Line Therapy for Patients with Wild-Type BRAF in Japan: A Single Center Retrospective StudyIkko Muto, Hiroshi Koga, Reiichi Doi, et al.
The Journal of Dermatology|April 10, 2017
Hematopoietic stem cell transplantation in advanced cutaneous T-cell lymphomaHiroshi Saruta, Chika Ohata, Ikko Muto, et al.
The American Journal of Dermatopathology|July 4, 2019
Sarcomatoid Variant of Primary Cutaneous Anaplastic Large Cell LymphomaYohei Natsuaki, Ikko Muto, Miyuki Kawamura, et al.
In Vivo (Athens, Greece)|June 27, 2024
Exploring Predictors of Hypertension Development With Pazopanib and Examining Predictive Performance Over TimeMasayuki Kunitake, Aya Goto, Yoshiro Sakai, et al.
The American Journal of Dermatopathology|October 1, 2019
Cutaneous Histiocytic Sarcoma With Cellular CannibalismAya Nanri, Eri Katayama, Taichi Imamura, et al.
Pathology, Research and Practice|January 23, 2023
Transcription factor activating enhancer-binding protein 2B expression correlates with invasiveness and prognosis of extramammary Paget's diseaseAya Kawaguchi, Jun Akiba, Sachiko Ogasawara, et al.
Anticancer Research|January 9, 2021
Programmed Death-Ligand 1 and Programmed Death-Ligand 2 Expression Can Affect Prognosis in Extramammary Paget's DiseaseAya Kawaguchi, Jun Akiba, Reiichiro Kondo, et al.
European Journal of Cancer (Oxford, England : 1990)|January 27, 2021
Outcome of combination therapy using BRAF and MEK inhibitors among Asian patients with advanced melanoma: An analysis of 112 casesYasuhiro Fujisawa, Takamichi Ito, Hiroshi Kato, et al.
The Journal of Dermatology|August 23, 2025
An Open-Label, Multicenter, Phase II Study of Bexarotene in Patients With Adult T-Cell Leukemia/LymphomaKentaro Yonekura, Ikko Muto, Motoi Takenaka, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Journal of Cutaneous Pathology|May 13, 2018
Adenodermatofibroma possessing dilated glandular structures with eccrine features: A case studyIkko Muto, Fumi Kuwahara, Takako Shintani, et al.
The Kurume Medical Journal|October 4, 2023
Efficacy of Nivolumab and Ipilimumab Combined Therapy as a First-Line Therapy for Patients with Advanced Melanoma and the Urgent Need for an Effective Second-Line Therapy for Patients with Wild-Type BRAF in Japan: A Single Center Retrospective StudyIkko Muto, Hiroshi Koga, Reiichi Doi, et al.
The Journal of Dermatology|April 10, 2017
Hematopoietic stem cell transplantation in advanced cutaneous T-cell lymphomaHiroshi Saruta, Chika Ohata, Ikko Muto, et al.
The American Journal of Dermatopathology|July 4, 2019
Sarcomatoid Variant of Primary Cutaneous Anaplastic Large Cell LymphomaYohei Natsuaki, Ikko Muto, Miyuki Kawamura, et al.
In Vivo (Athens, Greece)|June 27, 2024
Exploring Predictors of Hypertension Development With Pazopanib and Examining Predictive Performance Over TimeMasayuki Kunitake, Aya Goto, Yoshiro Sakai, et al.
The American Journal of Dermatopathology|October 1, 2019
Cutaneous Histiocytic Sarcoma With Cellular CannibalismAya Nanri, Eri Katayama, Taichi Imamura, et al.
Pathology, Research and Practice|January 23, 2023
Transcription factor activating enhancer-binding protein 2B expression correlates with invasiveness and prognosis of extramammary Paget's diseaseAya Kawaguchi, Jun Akiba, Sachiko Ogasawara, et al.
Anticancer Research|January 9, 2021
Programmed Death-Ligand 1 and Programmed Death-Ligand 2 Expression Can Affect Prognosis in Extramammary Paget's DiseaseAya Kawaguchi, Jun Akiba, Reiichiro Kondo, et al.
European Journal of Cancer (Oxford, England : 1990)|January 27, 2021
Outcome of combination therapy using BRAF and MEK inhibitors among Asian patients with advanced melanoma: An analysis of 112 casesYasuhiro Fujisawa, Takamichi Ito, Hiroshi Kato, et al.
The Journal of Dermatology|August 23, 2025
An Open-Label, Multicenter, Phase II Study of Bexarotene in Patients With Adult T-Cell Leukemia/LymphomaKentaro Yonekura, Ikko Muto, Motoi Takenaka, et al.
Pageof 2